These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2873439)
1. Variation in charge on red cells of patients with different glomerulopathies. Boulton-Jones JM; McWilliams G; Chandrachud L Lancet; 1986 Jul; 2(8500):186-9. PubMed ID: 2873439 [TBL] [Abstract][Full Text] [Related]
2. [Measurement of the charge on red blood cells in patients with various glomerulopathies]. Kitano Y Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):643-9. PubMed ID: 2214314 [TBL] [Abstract][Full Text] [Related]
3. Different erythrocyte and platelet surface electric charge in various types of glomerulonephritis. Klinger M; Kramarz S; Wendycz D; Kopec W Nephrol Dial Transplant; 1997 Apr; 12(4):707-12. PubMed ID: 9140998 [TBL] [Abstract][Full Text] [Related]
4. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111 [TBL] [Abstract][Full Text] [Related]
5. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy. Sakagami Y; Nakajima M; Takagawa K; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Kamitsuji H; Yoshioka A Nephron Clin Pract; 2004; 96(3):c96-104. PubMed ID: 15056992 [TBL] [Abstract][Full Text] [Related]
6. Glomerular charge selectivity in primary glomerulopathies. Fox JG; Quin JD; O'Reilly DS; Boulton-Jones JM Clin Sci (Lond); 1994 Oct; 87(4):421-5. PubMed ID: 7834994 [TBL] [Abstract][Full Text] [Related]
7. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease. Taira K; Hewitson TD; Kincaid-Smith P Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068 [TBL] [Abstract][Full Text] [Related]
8. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358 [TBL] [Abstract][Full Text] [Related]
12. Risk alleles for IgA nephropathy-associated SNPs conferred completely opposite effects to idiopathic membranous nephropathy in Chinese Han. Qin X; Wang C; Lu G; Peng M; Cheng G; Zhu H; Cao Y; Liu J; Li Y; Cai H; Yang F; Liu Y; Chen X; Li L; Wan N; Wen X; Li S; Nie R; Qin D; Li Y; Liu Y Immunol Res; 2017 Oct; 65(5):1059-1064. PubMed ID: 28929317 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy. Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862 [TBL] [Abstract][Full Text] [Related]
14. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study. Wang J; Juan C; Huang Q; Zeng C; Liu Z Nephrol Dial Transplant; 2013 Sep; 28(9):2339-45. PubMed ID: 23787555 [TBL] [Abstract][Full Text] [Related]
15. Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. Dong J; Zheng F; Liu F; He J; Li S; Pu W; Xu H; Luo Z; Liu S; Yin L; Tang D; Dai Y Front Immunol; 2023; 14():1131164. PubMed ID: 37033921 [TBL] [Abstract][Full Text] [Related]
16. [The incidence of renal diseases as diagnosed by biopsy in Hungary]. Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747 [TBL] [Abstract][Full Text] [Related]
17. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study. Handa T; Kakita H; Tateishi Y; Endo T; Suzuki H; Katayama T; Tsukamoto T; Muso E Clin Exp Nephrol; 2018 Oct; 22(5):1116-1127. PubMed ID: 29564665 [TBL] [Abstract][Full Text] [Related]
18. Occurrence of kidney diseases and patterns of glomerular disease based on a 10-year kidney biopsy material: a retrospective single-centre analysis in Estonia. Riispere Z; Ots-Rosenberg M Scand J Urol Nephrol; 2012 Oct; 46(5):389-94. PubMed ID: 22725262 [TBL] [Abstract][Full Text] [Related]
19. Histone-reactive IgA antibodies in adult IgA nephropathy and other primary glomerulonephritis. Monestier M; Fasy TM; Novick KE; Losman MJ; Rigal D; Wong GY; Terzidis-Trabelsi H; Pilatte Y; Rostoker G Nephron; 1994; 68(1):25-31. PubMed ID: 7527503 [TBL] [Abstract][Full Text] [Related]
20. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]